Skip to main content
Funded Studies

Antony A. Cooper, PhD

Associate Professor at Garvan Institute of Medical Research

Director at Australian Parkinson's Mission

Location: Sydney NSW Australia

Antony Cooper is the research director of the Australian Parkinson’s Mission (APM) and head of the Neurodegeneration & Neurogenomics Laboratory at the Garvan Institute of Medical Research (Australia). He completed his Bachelor’s degree with honours at the University of Otago (New Zealand) prior to a PhD at McGill University. After post-doctoral studies at the University of Oregon’s Institute of Molecular Biology, he gained tenure at the University of Missouri (1996) and then moved to the Garvan Institute (2006). His lab studies the molecular mechanisms of Parkinson’s Disease (PD). Since 2019, he has focused on the aims of the APM, which include accelerating the identification of disease-modifying PD treatments using a framework based on the integration of clinical trials with genomic stratification approaches, biomarker assay development and deployment and the application of relevant human cell models.


Associated Grants

  • Exploring How Mutations in Genes Associated with Parkinson’s Disease Alter the Activity of Other Genes

    2022


  • Single-molecule Detection of Oligomeric Synuclein in Body Fluids

    2020


  • Verification of a Long, Non-coding RNA in Blood as a Biomarker for Parkinson's Disease

    2014


  • The Role of Noncoding RNAs in Parkinson’s Disease

    2013


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.